BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18428938)

  • 1. Synthesis of acyclic nucleoside phosphonates.
    Holý A
    Curr Protoc Nucleic Acid Chem; 2005 Oct; Chapter 14():Unit 14.2. PubMed ID: 18428938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ester prodrugs of acyclic nucleoside thiophosphonates compared to phosphonates: synthesis, antiviral activity and decomposition study.
    Roux L; Priet S; Payrot N; Weck C; Fournier M; Zoulim F; Balzarini J; Canard B; Alvarez K
    Eur J Med Chem; 2013 May; 63():869-81. PubMed ID: 23603046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Versatile synthesis of oxime-containing acyclic nucleoside phosphonates--synthetic solutions and antiviral activity.
    Solyev PN; Jasko MV; Kleymenova AA; Kukhanova MK; Kochetkov SN
    Org Biomol Chem; 2015 Nov; 13(44):10946-56. PubMed ID: 26383895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordination Chemistry of Nucleotides and Antivirally Active Acyclic Nucleoside Phosphonates, including Mechanistic Considerations.
    Sigel A; Sigel H; Sigel RKO
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35565975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xanthine-based acyclic nucleoside phosphonates with potent antiviral activity against varicella-zoster virus and human cytomegalovirus.
    Baszczyňski O; Kaiser MM; Česnek M; Břehová P; Jansa P; Procházková E; Dračínský M; Snoeck R; Andrei G; Janeba Z
    Antivir Chem Chemother; 2018; 26():2040206618813050. PubMed ID: 30497281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the in vitro growth of Plasmodium falciparum by acyclic nucleoside phosphonates.
    Smeijsters LJ; Franssen FF; Naesens L; de Vries E; Holý A; Balzarini J; de Clercq E; Overdulve JP
    Int J Antimicrob Agents; 1999 Jun; 12(1):53-61. PubMed ID: 10389648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytostatic activity of antiviral acyclic nucleoside phosphonates in rodent lymphocytes.
    Zídek Z; Potmesil P; Holý A
    Toxicol Appl Pharmacol; 2003 Nov; 192(3):246-53. PubMed ID: 14575642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acyclic nucleoside phosphonates with a branched 2-(2-phosphonoethoxy)ethyl chain: efficient synthesis and antiviral activity.
    Hocková D; Holý A; Andrei G; Snoeck R; Balzarini J
    Bioorg Med Chem; 2011 Aug; 19(15):4445-53. PubMed ID: 21745746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acyclic nucleoside phosphonates (ANPs): Antonín Holý's legacy.
    De Clercq E
    Med Res Rev; 2013 Nov; 33(6):1278-303. PubMed ID: 23568857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some novel aminopropyl nucleoside phosphonates.
    Zhou D; Lagoja IM; Van Aerschot A
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):563-6. PubMed ID: 18066856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects.
    Krečmerová M; Majer P; Rais R; Slusher BS
    Front Chem; 2022; 10():889737. PubMed ID: 35668826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Anti-HIV Activity of Guanine Modified Fluorinated Acyclic Nucleoside Phosphonate Derivatives.
    Luo M; Groaz E; De Jonghe S; Schols D; Herdewijn P
    Chem Biodivers; 2019 Feb; 16(2):e1800532. PubMed ID: 30431702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the synthesis of cyclic 5'-nornucleoside phosphonate analogues.
    Shen GH; Hong JH
    Carbohydr Res; 2018 Jun; 463():47-106. PubMed ID: 29772449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantiopurity analysis of new types of acyclic nucleoside phosphonates by capillary electrophoresis with cyclodextrins as chiral selectors.
    Solínová V; Kaiser MM; Lukáč M; Janeba Z; Kašička V
    J Sep Sci; 2014 Feb; 37(3):295-303. PubMed ID: 24259415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Branched acyclic nucleoside phosphonates as monomers for the synthesis of modified oligonucleotides.
    Hocková D; Rosenbergová Š; Ménová P; Páv O; Pohl R; Novák P; Rosenberg I
    Org Biomol Chem; 2015 Apr; 13(15):4449-58. PubMed ID: 25766752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of α-L-threose nucleoside phosphonates via regioselective sugar protection.
    Dumbre SG; Jang MY; Herdewijn P
    J Org Chem; 2013 Jul; 78(14):7137-44. PubMed ID: 23822647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro.
    Hartline CB; Gustin KM; Wan WB; Ciesla SL; Beadle JR; Hostetler KY; Kern ER
    J Infect Dis; 2005 Feb; 191(3):396-9. PubMed ID: 15633099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyclic Nucleoside Phosphonates Containing 9-Deazahypoxanthine and a Five-Membered Heterocycle as Selective Inhibitors of Plasmodial 6-Oxopurine Phosphoribosyltransferases.
    Kaiser MM; Baszczyňski O; Hocková D; Poštová-Slavětínská L; Dračínský M; Keough DT; Guddat LW; Janeba Z
    ChemMedChem; 2017 Jul; 12(14):1133-1141. PubMed ID: 28628279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical Synthesis of Acyclic Nucleoside Phosphonate Analogs Linked with Cyclic Systems between the Phosphonate and the Base Moieties.
    Shen GH; Hong JH
    Curr Med Chem; 2020; 27(35):5918-5948. PubMed ID: 31250746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Evaluation of Novel Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium falciparum and Human 6-Oxopurine Phosphoribosyltransferases.
    Kaiser MM; Hocková D; Wang TH; Dračínský M; Poštová-Slavětínská L; Procházková E; Edstein MD; Chavchich M; Keough DT; Guddat LW; Janeba Z
    ChemMedChem; 2015 Oct; 10(10):1707-23. PubMed ID: 26368337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.